Ig J chain Inhibitors
Ig J chain inhibitors are a class of chemicals that can potentially modulate the expression of the J chain protein indirectly through the inhibition of specific signaling pathways. The J chain is a small, soluble protein that plays a key role in the polymerization and secretion of polymeric IgM and IgA antibodies. It appears that the PI3K/Akt and MAPK pathways are key players in the regulation of J chain expression. The inhibitors listed here are all known to target key components of these pathways, which can potentially result in a decreased expression of the J chain. For example, U0126 and PD98059 are specific inhibitors of MEK1/2 and MEK1 respectively, which are upstream components of the MAPK pathway. By inhibiting these kinases, the signal transduction through the MAPK pathway can be reduced, which can potentially decrease J chain expression. Similarly, LY294002 and Wortmannin are inhibitors of PI3K, a key component of the PI3K/Akt pathway. By inhibiting PI3K, thesechemicals can decrease signal transduction through the PI3K/Akt pathway, which can potentially reduce J chain expression.
Another class of inhibitors that are included in this list are receptor tyrosine kinase inhibitors such as PD153035, Lapatinib, and Gefitinib. These inhibitors target the EGFR tyrosine kinase, which, when activated, can stimulate both the PI3K/Akt and MAPK pathways. By inhibiting EGFR, these chemicals can decrease signal transduction through these pathways, potentially reducing J chain expression. Finally, there are non-specific kinase inhibitors such as Quercetin and Genistein, which can inhibit several kinases involved in the PI3K/Akt and MAPK pathways. By inhibiting these kinases, these chemicals can decrease signal transduction through these pathways, potentially reducing J chain expression. Overall, these inhibitors can potentially act as indirect inhibitors of the J chain by influencing the PI3K/Akt and MAPK pathways.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. PI3K is a part of the PI3K/Akt pathway, which is known to regulate J chain expression. By inhibiting PI3K, LY294002 can decrease signal transduction through the PI3K/Akt pathway, potentially reducing J chain expression. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another potent PI3K inhibitor. Similar to LY294002, it can decrease signal transduction through the PI3K/Akt pathway, potentially reducing J chain expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a specific inhibitor of MEK1. By inhibiting MEK1, this drug can reduce signal transduction through the MAPK pathway, potentially decreasing J chain expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a selective inhibitor of JNK. JNK is a part of the MAPK pathway which is involved in the regulation of J chain expression. Inhibition of JNK by SP600125 can reduce the signal transduction through the MAPK pathway, leading to a potential decrease in J chain expression. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAPK. By inhibiting p38 MAPK, SB203580 can reduce signal transduction through the MAPK pathway, potentially decreasing J chain expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is a specific inhibitor of mTOR, which is involved in the PI3K/Akt pathway. By inhibiting mTOR, Rapamycin can decrease signal transduction through the PI3K/Akt pathway, potentially reducing J chain expression. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin is a non-specific inhibitor of several kinases involved in the PI3K/Akt and MAPK pathways. By inhibiting these kinases, Quercetin can decrease signal transduction through these pathways, potentially reducing J chain expression. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is an inhibitor of tyrosine kinases, which are involved in both the PI3K/Akt and MAPK pathways. By inhibiting these kinases, Genistein can decrease signal transduction through these pathways, potentially reducing J chain expression. | ||||||
PD 153035 | 153436-54-5 | sc-205909 | 5 mg | $146.00 | 5 | |
PD 153035 is an inhibitor of the EGFR tyrosine kinase. EGFR activation can stimulate both the PI3K/Akt and MAPK pathways. By inhibiting EGFR, PD153035 can decrease signal transduction through these pathways, potentially reducing J chain expression. | ||||||
Lapatinib | 231277-92-2 | sc-353658 | 100 mg | $420.00 | 32 | |
Lapatinib is a dual inhibitor of EGFR and HER2/neu, both of which can stimulate the PI3K/Akt and MAPK pathways. By inhibiting these receptors, Lapatinib can decrease signal transduction through these pathways, potentially reducing J chain expression. | ||||||